APOC2 and neoplasm: The remaining three subpopulations, namely MLB (86.0%), GPAM+ macrophages (74.2%), and APOC2+ macrophages (87.7%), were significantly enriched in the pCR group (Figure 2A), suggesting potential anti-tumor or ICB-sensitizing roles.